S. Green

Lifetime Economic Burden of Crohn's Disease and Ulcerative Colitis by Age at Diagnosis.

R. Baldassano, Ahva Shahabi, S. Seabury, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Increased Lifetime Risk of Intestinal Complications and Extraintestinal Manifestations in Crohn's Disease and Ulcerative Colitis.

R. Baldassano, Ahva Shahabi, S. Seabury, 2022, Gastroenterology & hepatology.

P014 AVERAGE ANNUAL HEALTHCARE COSTS FOR PEDIATRIC AND ADULT PATIENTS WITH CROHN’S DISEASE OR ULCERATIVE COLITIS

R. Baldassano, Ahva Shahabi, S. Seabury, 2018 .

The Total Direct Cost of Healthcare in the United States in Patients with Crohn's Disease and Ulcerative Colitis: An Age Specific Analysis

R. Baldassano, Ahva Shahabi, S. Seabury, 2017 .

The social value of childhood vaccination in the United States.

A. Chit, W. Aubry, Philip Hosbach, 2016, The American journal of managed care.

The economic burden of switching targeted disease-modifying anti-rheumatic drugs among rheumatoid arthritis patients

Ahva Shahabi, J. Shafrin, T. Curtice, 2019, Journal of medical economics.

Cost sharing for antiepileptic drugs: medication utilization and health plan costs.

D. Grabowski, D. Labiner, N. Joyce, 2018, The American journal of managed care.